/ / /
Jeffrey joined Gurnet Point Capital in 2020 and currently is an Associate on the investment team. He is involved in all aspects of the investment process, including sourcing, due diligence, transaction execution and portfolio support.
Prior to joining Gurnet Point, he was an Analyst in the Healthcare Investment Banking Group at Lazard, where he engaged in M&A transactions and Corporate Advisory. He began his career in research at Memorial Sloan Kettering Cancer Center where he became a three-time peer-reviewed author for his work on radio-pharmaceuticals.
Jeffrey graduated from Cornell University, where he received his B.S. in Biological Sciences and Applied Economics & Management.